Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Rasl11a | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RASL11A mRNA | CTD | PMID:22079256 | Rasl11a | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Rasl11a (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of RASL11A mRNA | CTD | PMID:22206623 | Rasl11a | Rat | 17beta-estradiol | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Estradiol results in increased expression of RASL11A mRNA | CTD | PMID:31614463 | Rasl11a | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rasl11a (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RASL11A mRNA | CTD | PMID:21570461 | Rasl11a | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RASL11A mRNA | CTD | PMID:33387578|PMID:34747641 | Rasl11a | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Rasl11a (Mus musculus) | 6480464 | 2,2',4,4',5-brominated diphenyl ether affects the expression of RASL11A mRNA | CTD | PMID:38648751 | Rasl11a | Rat | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | EXP | | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of RASL11A mRNA | CTD | PMID:23196670 | Rasl11a | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Rasl11a (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of RASL11A mRNA | CTD | PMID:20188158 | Rasl11a | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Rasl11a | Rat | 4-hydroxyphenyl retinamide | increases expression | ISO | Rasl11a (Mus musculus) | 6480464 | Fenretinide results in increased expression of RASL11A mRNA | CTD | PMID:28973697 | Rasl11a | Rat | 9-cis-retinoic acid | increases expression | EXP | | 6480464 | Alitretinoin results in increased expression of RASL11A mRNA | CTD | PMID:16648578 | Rasl11a | Rat | acrylamide | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Acrylamide results in increased expression of RASL11A mRNA | CTD | PMID:32763439 | Rasl11a | Rat | aflatoxin B1 | increases methylation | ISO | RASL11A (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of RASL11A exon | CTD | PMID:30157460 | Rasl11a | Rat | all-trans-retinoic acid | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Tretinoin results in increased expression of RASL11A mRNA | CTD | PMID:23830798 | Rasl11a | Rat | all-trans-retinoic acid | decreases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of RASL11A mRNA | CTD | PMID:33167477 | Rasl11a | Rat | aristolochic acid A | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of RASL11A mRNA | CTD | PMID:33212167 | Rasl11a | Rat | arsenous acid | decreases expression | ISO | Rasl11a (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of RASL11A mRNA | CTD | PMID:39716349 | Rasl11a | Rat | benzo[a]pyrene | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ... | CTD | PMID:27858113 | Rasl11a | Rat | benzo[a]pyrene | decreases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of RASL11A mRNA | CTD | PMID:32234424 | Rasl11a | Rat | benzo[a]pyrene | decreases methylation | ISO | RASL11A (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of RASL11A promoter | CTD | PMID:27901495 | Rasl11a | Rat | benzo[a]pyrene | affects methylation | ISO | RASL11A (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of RASL11A exon | CTD | PMID:30157460 | Rasl11a | Rat | benzo[a]pyrene | decreases methylation | ISO | Rasl11a (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of RASL11A 3' UTR; Benzo(a)pyrene results in decreased methylation of more ... | CTD | PMID:27901495 | Rasl11a | Rat | benzo[b]fluoranthene | decreases expression | ISO | Rasl11a (Mus musculus) | 6480464 | benzo(b)fluoranthene results in decreased expression of RASL11A mRNA | CTD | PMID:26377693 | Rasl11a | Rat | benzo[b]fluoranthene | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ... | CTD | PMID:27858113 | Rasl11a | Rat | bexarotene | increases expression | EXP | | 6480464 | bexarotene results in increased expression of RASL11A mRNA | CTD | PMID:16648578 | Rasl11a | Rat | bisphenol A | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Rasl11a | Rat | bisphenol A | increases expression | ISO | Rasl11a (Mus musculus) | 6480464 | bisphenol A results in increased expression of RASL11A mRNA | CTD | PMID:32156529 | Rasl11a | Rat | bisphenol A | decreases expression | ISO | Rasl11a (Mus musculus) | 6480464 | bisphenol A results in decreased expression of RASL11A mRNA | CTD | PMID:35479511 | Rasl11a | Rat | bisphenol F | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Rasl11a | Rat | calcidiol | decreases expression | EXP | | 6480464 | Calcifediol deficiency results in decreased expression of RASL11A mRNA | CTD | PMID:17293106 | Rasl11a | Rat | calcitriol | decreases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of RASL11A mRNA | CTD | PMID:21592394 | Rasl11a | Rat | calcitriol | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RASL11A mRNA | CTD | PMID:21592394 | Rasl11a | Rat | carbon nanotube | increases expression | ISO | Rasl11a (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in increased expression of RASL11A mRNA; Nanotubes, Carbon results in increased more ... | CTD | PMID:25554681 | Rasl11a | Rat | CGP 52608 | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to RASL11A gene] | CTD | PMID:28238834 | Rasl11a | Rat | chloroprene | increases expression | ISO | Rasl11a (Mus musculus) | 6480464 | Chloroprene results in increased expression of RASL11A mRNA | CTD | PMID:23125180 | Rasl11a | Rat | choline | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Rasl11a | Rat | chrysene | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ... | CTD | PMID:27858113 | Rasl11a | Rat | cisplatin | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Cisplatin results in increased expression of RASL11A mRNA | CTD | PMID:27392435 | Rasl11a | Rat | cocaine | increases expression | EXP | | 6480464 | Cocaine results in increased expression of RASL11A mRNA | CTD | PMID:27899881 | Rasl11a | Rat | copper atom | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression more ... | CTD | PMID:15467011 | Rasl11a | Rat | copper(0) | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression more ... | CTD | PMID:15467011 | Rasl11a | Rat | copper(II) chloride | decreases expression | ISO | RASL11A (Homo sapiens) | 6480464 | cupric chloride results in decreased expression of RASL11A mRNA | CTD | PMID:38568856 | Rasl11a | Rat | crocidolite asbestos | affects expression | ISO | RASL11A (Homo sapiens) | 6480464 | Asbestos, Crocidolite affects the expression of RASL11A mRNA | CTD | PMID:25757056 | Rasl11a | Rat | dexamethasone | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Dexamethasone results in increased expression of RASL11A mRNA | CTD | PMID:25047013 | Rasl11a | Rat | dexamethasone | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Rasl11a | Rat | diarsenic trioxide | decreases expression | ISO | Rasl11a (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of RASL11A mRNA | CTD | PMID:39716349 | Rasl11a | Rat | dibutyl phthalate | increases expression | ISO | Rasl11a (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of RASL11A mRNA | CTD | PMID:21266533 | Rasl11a | Rat | dimethyl sulfoxide | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Dimethyl Sulfoxide results in increased expression of RASL11A mRNA | CTD | PMID:39709020 | Rasl11a | Rat | dimethylarsinic acid | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Rasl11a | Rat | endosulfan | affects expression | EXP | | 6480464 | Endosulfan affects the expression of RASL11A mRNA | CTD | PMID:29391264 | Rasl11a | Rat | folic acid | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Rasl11a | Rat | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of RASL11A gene | CTD | PMID:22079235 | Rasl11a | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of RASL11A mRNA | CTD | PMID:33387578 | Rasl11a | Rat | glycidol | decreases expression | EXP | | 6480464 | glycidol results in decreased expression of RASL11A mRNA | CTD | PMID:24915197 | Rasl11a | Rat | indometacin | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] more ... | CTD | PMID:28628672 | Rasl11a | Rat | ketamine | increases expression | EXP | | 6480464 | Ketamine results in increased expression of RASL11A mRNA | CTD | PMID:20080153 | Rasl11a | Rat | L-methionine | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Rasl11a | Rat | lead(0) | decreases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Lead results in decreased expression of RASL11A mRNA | CTD | PMID:19921347 | Rasl11a | Rat | Licochalcone B | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | licochalcone B results in increased expression of RASL11A mRNA | CTD | PMID:33647349 | Rasl11a | Rat | lipopolysaccharide | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Lipopolysaccharides results in increased expression of RASL11A mRNA | CTD | PMID:35811015 | Rasl11a | Rat | lipopolysaccharide | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RASL11A mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction more ... | CTD | PMID:35811015 | Rasl11a | Rat | manganese(II) chloride | decreases expression | EXP | | 6480464 | manganese chloride results in decreased expression of RASL11A mRNA | CTD | PMID:28801915 | Rasl11a | Rat | menadione | affects expression | ISO | RASL11A (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of RASL11A mRNA | CTD | PMID:20044591 | Rasl11a | Rat | methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of RASL11A mRNA | CTD | PMID:19564919 | Rasl11a | Rat | methamphetamine | multiple interactions | EXP | | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of RASL11A mRNA | CTD | PMID:19564919 | Rasl11a | Rat | methylarsonic acid | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Rasl11a | Rat | methylisothiazolinone | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of RASL11A mRNA | CTD | PMID:31629900 | Rasl11a | Rat | methylmercury chloride | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of RASL11A mRNA | CTD | PMID:28001369 | Rasl11a | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... | CTD | PMID:39752319 | Rasl11a | Rat | monobenzyl phthalate | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... | CTD | PMID:39752319 | Rasl11a | Rat | Monobutylphthalate | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... | CTD | PMID:39752319 | Rasl11a | Rat | monoethyl phthalate | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with monobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-isobutyl more ... | CTD | PMID:39752319 | Rasl11a | Rat | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of RASL11A mRNA | CTD | PMID:28801915 | Rasl11a | Rat | O-methyleugenol | decreases expression | ISO | RASL11A (Homo sapiens) | 6480464 | methyleugenol results in decreased expression of RASL11A mRNA | CTD | PMID:32234424 | Rasl11a | Rat | okadaic acid | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Okadaic Acid results in increased expression of RASL11A mRNA | CTD | PMID:38832940 | Rasl11a | Rat | ozone | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased more ... | CTD | PMID:34911549 | Rasl11a | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of RASL11A mRNA | CTD | PMID:33387578 | Rasl11a | Rat | perfluorohexanesulfonic acid | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | perfluorohexanesulfonic acid results in increased expression of RASL11A mRNA | CTD | PMID:25812627 | Rasl11a | Rat | perfluorononanoic acid | decreases expression | ISO | RASL11A (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of RASL11A mRNA | CTD | PMID:25812627 | Rasl11a | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in increased expression of RASL11A mRNA | CTD | PMID:25812627 | Rasl11a | Rat | potassium chromate | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RASL11A mRNA | CTD | PMID:22079256 | Rasl11a | Rat | potassium chromate | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of RASL11A mRNA | CTD | PMID:22079256 | Rasl11a | Rat | progesterone | increases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Progesterone results in increased expression of RASL11A mRNA | CTD | PMID:20864642 | Rasl11a | Rat | rotenone | increases expression | ISO | Rasl11a (Mus musculus) | 6480464 | Rotenone results in increased expression of RASL11A mRNA | CTD | PMID:32937126 | Rasl11a | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in increased expression of RASL11A mRNA; S-(1,2-dichlorovinyl)cysteine inhibits the reaction more ... | CTD | PMID:35811015 | Rasl11a | Rat | SCH 23390 | multiple interactions | EXP | | 6480464 | [Methamphetamine co-treated with SCH 23390] results in decreased expression of RASL11A mRNA | CTD | PMID:19564919 | Rasl11a | Rat | sodium arsenate | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Rasl11a | Rat | sodium arsenite | decreases expression | ISO | RASL11A (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of RASL11A mRNA | CTD | PMID:29301061 | Rasl11a | Rat | sodium arsenite | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... | CTD | PMID:34876320 | Rasl11a | Rat | sodium arsenite | decreases expression | ISO | Rasl11a (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of RASL11A mRNA | CTD | PMID:37682722 | Rasl11a | Rat | sotorasib | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of RASL11A mRNA | CTD | PMID:36139627 | Rasl11a | Rat | sulforaphane | decreases expression | ISO | RASL11A (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of RASL11A mRNA | CTD | PMID:31838189 | Rasl11a | Rat | sunitinib | decreases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of RASL11A mRNA | CTD | PMID:31533062 | Rasl11a | Rat | testosterone | decreases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Testosterone results in decreased expression of RASL11A mRNA | CTD | PMID:21592394 | Rasl11a | Rat | testosterone | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RASL11A mRNA | CTD | PMID:21592394 | Rasl11a | Rat | tetraphene | multiple interactions | ISO | Rasl11a (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in decreased expression of more ... | CTD | PMID:27858113 | Rasl11a | Rat | titanium dioxide | decreases expression | ISO | Rasl11a (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of RASL11A mRNA | CTD | PMID:27760801 | Rasl11a | Rat | titanium dioxide | decreases methylation | ISO | Rasl11a (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of RASL11A gene | CTD | PMID:35295148 | Rasl11a | Rat | titanium dioxide | decreases expression | EXP | | 6480464 | titanium dioxide results in decreased expression of RASL11A mRNA | CTD | PMID:30012374 | Rasl11a | Rat | trametinib | multiple interactions | ISO | RASL11A (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of RASL11A mRNA | CTD | PMID:36139627 | Rasl11a | Rat | triphenyl phosphate | affects expression | ISO | RASL11A (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of RASL11A mRNA | CTD | PMID:37042841 | Rasl11a | Rat | tunicamycin | decreases expression | ISO | RASL11A (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of RASL11A mRNA | CTD | PMID:29453283 | |






















